London, the offices of The Lancet.
A brown envelope containing a strange paper had arrived. A new electrophoresis technique, a new hypothesis, a new disease, a new disease mechanism.
It was a paper written with a certain flair.
I—and my research institution—know about things like this; we can come up with ideas like this.
Dr. Ashcroft scratched his head. What kind of person would write something like this?
“What on earth is toxic shock syndrome?”
It was an almost impossibly complicated paper. It read like an Agatha Christie mystery.
The paper began with the case of a young woman who had collapsed despite having no medical history or anything unusual about her. She was showing symptoms consistent with shock.
And then……. An inserted tampon was discovered by a resident in the ER.
It had probably been soaked in blood and was serving as a culture medium.
The tampon in question was removed. But suspicious circumstances suggested it wasn't a simple infection, so they began investigating further.
An examination of the tampon's structure, an explanation of superabsorbent polymer resin, bacterial culture experiments, protein electrophoresis.
And even a proposal about how the toxin worked. It was a nail-biting story.
He read it all in one sitting.
Dr. Ashcroft could only marvel. It was written like a novel narrated from the perspective of a detective hunting a murderer.
So you could write a paper like this.
It wasn't structured like a traditional paper, but it was sure to change the world. Dr. Ashcroft gazed into space, lost in thought.
***
Meanwhile. I still had a few things to do.
At last, the design for the Helicobacter pylori diagnostic kit I'd been preparing for the past few days was complete. All I had to do now was take it to a pharmaceutical company.
This would be the fastest way to make Helicobacter pylori treatment widely available. You couldn't treat it until you diagnosed it, after all.
I contacted Syntex again, the pharmaceutical company I'd sold the EpiPen patent to before.
-Hello, Dr. Parks. You're the doctor who brought your epinephrine injector patent to our company, right?
-Drug-related patents usually take several years to reach the market, but thanks to you, things are progressing smoothly. Thank you. If you have something new to discuss, I'll arrange an appointment.
This time, I could go see Syntex without Weizmann's help.
This was Syntex's boardroom.
Dr. Bowers, whom I'd met last time, sat across the boardroom from me and looked my way. I had a stack of papers and a chalkboard in front of me as I looked at him.
Dr. Bowers was the CEO of this pharmaceutical company. Several employees in black suits sat on either side of him.
Dr. Bowers spoke right away.
“It's good to see you again. I heard you were the first to report toxic shock syndrome a few days ago. Congratulations on your new research.”
“That's right.”
The pharmaceutical company employees murmured among themselves, their expressions serious.
“What brings you here today? My secretary told me earlier that Dr. Parks had brought a way to diagnose a new bacterium. Though I don't think she understood what it was.”
“A new bacterial diagnostic kit.”
Their reaction was lukewarm.
At first glance, it didn't seem like a product that could make much money. Hearing only “bacterial diagnostic kit,” one could see why.
“I'm not sure that'll make money.”
I scratched my head for a moment.
“Doctors may be interested in a newly discovered bacterium, but it's unclear whether it has any significance for running the company or public health.”
There was something I sometimes forgot.
‘If you do this, you can save lives!’ wasn’t a currency accepted everywhere in the world. Most people would scratch their heads and wonder why it was something they personally needed to do.
Dr. Bowers's response today was like that.
Dr. Bowers was just an executive responsible for the employees; he wasn't someone who'd sworn an oath to save patients. It wasn't his job.
I thought about how to answer.
“Uh……. This bacterium that causes stomach ulcers was discovered this year. In fact, the idea that stomach ulcers are caused by bacteria was only published in a paper this year. We can start development ten years ahead of our competitors.”
“Is that so?”
“There are millions of stomach ulcer patients in the United States. Hundreds of thousands more are added every year, and there are even more if you include other countries.”
I could almost hear the gears turning in Dr. Bowers's head.
Even in the modern era, the market for urease test kits must have been worth trillions of won.
Probably?
“Hundreds of thousands every year……. That sounds like a lot, but also like not that many.”
“I know this may sound silly coming from me, but one patient doesn't just get tested once, do they?”
Dr. Bowers looked like he hadn't thought of that, and quietly nodded in agreement.
“Ah. It's worth investing in.”
“Even so, if Syntex moves now, it can corner the market. This is a field where research only began a few weeks ago, after all.”
Dr. Bowers nodded.
“Could you explain how it works?”
“Oh, it's simple. Helicobacter pylori has an enzyme that breaks down urea into ammonia and carbon dioxide. Ammonia has the effect of neutralizing stomach acid.”
“I suppose it does.”
“Carbon dioxide becomes a gas and can leave the body through the mouth. So, if you add a carbon isotope to urea and have the patient drink it, Helicobacter pylori breaks it down.”
I explained while drawing on the chalkboard the pharmaceutical company had prepared, though it was all in the design documents.
“Ah……. I never would have thought of that. So this method doesn't require an endoscopy, either?”
I nodded.
“That's right. It's simple, too: you just drink the urea and blow into a bag. Then the hospital can use its equipment to check for carbon dioxide produced from the urea.”
“That sounds good.”
“Can you make this?”
The pharmaceutical company employees spread out the papers I'd brought and began discussing them among themselves.
They could do it, right? There hadn't been anything in the process I'd explained that didn't exist in the 1970s. It was all possible as long as they knew the method.
“Yes. We can definitely manage something like this.”
Syntex's conference room fell quiet for a moment.
***
Dr. Bowers sighed and cleared away the papers scattered across the conference room table.
As if he'd reached a conclusion.
“All right, Dr. Parks. But would it be all right if I added one condition?”
“Yes?”
“Before you came today, I asked the researchers at the company to print out every paper with your name on it.”
There must've been quite a few.
I scratched my head.
“A lot?”
“The employees printed out ten papers, then said they'd need to look for more, so I told them to stop. Just how many have you written?”
“Quite a few.”
If I included not just the papers I'd written, but also the ones I'd participated in researching and had my name on, there'd really be an enormous number. Dr. Bowers chuckled.
“Well……. I suppose I underestimated you. I thought you were just a doctor who'd brought me an interesting invention. Maybe it isn't a lie that you're the medical world's von Neumann.”
“You're too kind.”
“My researchers explained that this is enough to rewrite the textbooks……. Here's my proposal, Dr. Parks.”
He looked at me.
“Yes.”
“I'll make this urease test patent a reality quickly……. That's what you really want, isn't it, Dr. Parks?”
It was future knowledge, after all.
Money wasn't the only thing that mattered. What mattered was quickly bringing new diagnostic techniques and treatments into reality so they could help patients.
“That's right.”
“Then let's use the same terms as the EpiPen. The company will pay you $100,000 upfront, plus a one-percent royalty on sales.”
“Ah, thank you.”
Dr. Bowers grinned.
“I'm being generous. In return, if you have anything else that needs to be made a reality, I'd like you to come to me.”
I thanked Dr. Bowers. I hadn't expected much money, since this was obviously going to sell less than the EpiPen, but this actually worked?
“Thank you for your time.”
“Please come by often. I'll see if there's anything I can do to help, or if you have the key to a new disease breakthrough that can be brought into reality.”
That was how things ended.
Another success.
I gathered my things and left the Syntex building.
I hadn't expected it, but I got the same amount and the same royalty rate as when I sold the EpiPen patent. The company had believed me.
Maybe Dr. Bowers had been convinced in the end.
***
Meanwhile. Somewhere in the California countryside.
Liselotte looked out the window.
This was Weizmann's estate.
Beneath California's painfully vivid blue spring sky, colorful wildflowers carpeted the horizon among the oak groves.
Looking a little closer.
In the garden of Weizmann's estate, preparations were underway for the upcoming Easter celebration.
There wasn't anything elaborate planned. They were just going to hide toy eggs around the estate and garden for an Easter egg hunt.
Liselotte smiled quietly as she looked at the scenery outside the window. If she invited them to the event, would they come? They seemed like they might be busy.
I hope they come, though.